CD274 and digestive system neoplasm: The pattern of expression and potential of PD‐L1 as an immunohistochemical biomarker has been extensively studied in gastrointestinal neoplasms (Mastracci et al., 2022) but a comprehensive glycan analysis has not yet been reported.